Inhibikase Therapeutics, Inc. (IKT)

NASDAQHealth CareBiotechnologySnapshot 2026-11-04

$1.44-8.28%

Close 2026-11-05 · 1-day change

Inhibikase Therapeutics, Inc. (IKT) Outlook: What's Priced In | QuarterlyIQ

Outlook evidence is being refreshed

A complete, current evidence snapshot is not available for this company yet.

Price, analyst earnings & P/E reference

The EPS and P/E reference is not available for IKT yet.

Measure / period	Management expectations	Analyst expectations

Management figures unavailable.

Current consensus figures unavailable.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.